A new multi-stakeholder framework is proposing how to better disseminate medical and clinical research using real-world data
Big data plays a huge role in advancing clinical science that improves patients’ lives around the world. Technological developments have resulted in the routine use of structured electronic healthcare records to fill key gaps in clinical evidence. Research that uses routinely collected, structured healthcare data could make a major impact if properly disseminated.
However, challenges such as verification, validation and data privacy are limiting the use and acceptance of evidence generated from using structured healthcare data. A well-defined and transparent approach is needed to address these issues.
Framework for an extensive audience of international stakeholders
The EU- and industry-funded BigData Heart project put forward a framework to enhance the reliability and quality of studies that use healthcare data. The approach should also build confidence for those who use the results for clinical decision support.
The CODE-EHR Minimum Standards Framework was compiled by many different stakeholders. They mainly included patients, patient advocacy groups, regulators, government agencies and leading medical journals, as well as representatives from professional societies, academic institutions, the pharmaceutical industry and payers.
Participants looked at opportunities and challenges and developed practical guidance on how healthcare data can be applied to research across many diseases. BigData Heart co-ordinated this massive undertaking. The framework was simultaneously published in The BMJ, The Lancet Digital Health and the European Heart Journal.
More vigorous and efficient use of healthcare data for research
Lead author Professor Dipak Kotecha, of project partner the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust in the UK, said in a press release posted on the European Society of Cardiology website: “With the support of patients and the public, routinely collected healthcare information provides an exciting opportunity to answer important clinical questions in populations representative of our communities.
“Our ability to apply findings from studies that use these data sources is critically dependent on transparency at every stage. This international framework will enable robust and effective use of healthcare data for clinical research and provide those working in this field with guidance on how to design better studies for maximal benefit to patient care.”
The framework offers researchers step-by-step advice for achieving suitable governance and transparency. Various stakeholders will now be able to rely on the reported findings. Minimum standards are set forth for five key areas: data set construction and linkage; data fit for purpose; disease outcome and definitions; analysis; and ethics and governance.
Co-author Professor Folkert Asselbergs, of project co-ordinator University Medical Center Utrecht (Netherlands) and project partner University College London, concluded: “The use of real-world data in large-scale registries and randomised trials is ushering in a new era of clinical evidence generation.
“The CODE-EHR framework addresses public concerns about data sharing and provides greater clarity on the use of real-world healthcare data for a broad range of stakeholders to improve clinical care.”
By using novel statistical, machine learning and data mining methodologies, BigData Heart aims to improve patient outcomes and lessen the societal burden of acute coronary syndrome, atrial fibrillation and heart failure. The project ends in February 2023.
BigData Heart is supported by the Innovative Medicines Initiative, a partnership between the EU and the European pharmaceutical industry.
Image credit: Cottonbro